XML 48 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
Preferred Stock and Warrants
3 Months Ended
Mar. 31, 2015
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]  
Preferred Stock and Warrants
Note 8.
Preferred Stock and Warrants
 
A summary of the Company’s preferred stock as of March 31, 2015 and December 31, 2014 is as follows.
 
 
 
March 31,
 
December 31,
 
 
 
2015
 
2014
 
 
 
(unaudited)
 
 
 
 
 
 
Shares Issued &
 
Shares Issued &
 
Offering
 
Outstanding
 
Outstanding
 
Series A convertible
 
 
47,250
 
 
47,250
 
Series B convertible, 10% cumulative dividend
 
 
93,750
 
 
93,750
 
Series C convertible, 10% cumulative dividend
 
 
38,333
 
 
38,333
 
Series D convertible, 10% cumulative dividend
 
 
-
 
 
175,000
 
Series E convertible, 10% cumulative dividend
 
 
19,022
 
 
19,022
 
Total Preferred Stock
 
 
198,355
 
 
373,355
 
 
As of March 31, 2015 and December 31, 2014, the Company had cumulative preferred undeclared and unpaid dividends. In accordance with the Financial Accounting Standard Board’s Accounting Standards Codification 260-10-45-11, “Earnings per Share”, these dividends were added to the net loss in the net loss per share calculation.
 
On February 23, 2015, the Company reached an agreement with Ventana Medical Systems, Inc. to convert $175,000 stated value of Series D Preferred Stock and all outstanding accrued dividends of $656,250 for 12,000 shares of the Company’s common stock.
 
Summary of Preferred Stock Terms
 
Series A Convertible Preferred Stock
Liquidation Value:
$4.50 per share, $212,625
Conversion Price:
$10,303 per share
Conversion Rate:
0.00044—Liquidation Value divided by Conversion Price ($4.50/$10,303)
Voting Rights:
None
Dividends:
None
Conversion Period:
Any time
 
Series B Convertible Preferred Stock
Liquidation Value:
$4.00 per share, $375,000
Conversion Price:
$1,000 per share
Conversion Rate:
0.0040—Liquidation Value divided by Conversion Price ($4.00/$1,000)
Voting Rights:
None
Dividends:
10%—Quarterly—Commencing March 31, 2001
Conversion Period:
Any time
Cumulative dividends in arrears at March 31, 2015 and December 31, 2014 were $530,038 and $520,665, respectively.
  
Series C Convertible Preferred Stock
Liquidation Value:
$3.00 per share, $115,000
Conversion Price:
$600 per share
Conversion Rate:
0.0050—Liquidation Value divided by Conversion Price ($3.00/$600)
Voting Rights:
None
Dividends:
10%—Quarterly—Commencing March 31, 2002
Conversion Period:
Any time
Cumulative dividends in arrears at March 31, 2015 and December 31, 2014 were $154,288 and $151,413, respectively.
 
Series E Convertible Preferred Stock
Liquidation Value:
$22.00 per share, $418,488
Conversion Price:
$800.00 per share
Conversion Rate:
.0275—Liquidation Value divided by Conversion Price ($22.00/$800)
Voting Rights:
Equal in all respects to holders of common shares
Dividends:
10%—Quarterly—Commencing May 31, 2002
Conversion Period:
Any time
Cumulative dividends in arrears at March 31, 2015 and December 31, 2014 were $568,177 and $558,173 respectively.
 
Warrants outstanding
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
Weighted
 
 
 
Average
 
 
 
 
 
Average
 
Aggregate
 
Remaining
 
 
 
Options and
 
Exercise
 
Intrinsic
 
Contractual
 
 
 
Warrants
 
Price
 
Value
 
Life (Years)
 
Outstanding at December 31, 2014
 
143,308
 
$
2.64
 
 
6.46
 
Granted
 
 
$
 
 
 
Exercised
 
 
 
 
 
 
Expired
 
 
 
 
 
 
Outstanding at December 31, 2013
 
143.308
 
$
2.64
 
 
6.46